Status | Study |
Completed |
Study Name: Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy Condition: Sialorrhea Cerebral Palsy Date: 2011-11-29 Interventions: Biological: BOTULINUM NEUROTOXIN TYPE-A Botulinum toxin type A / First infiltration: 25U in each salivar |
Completed |
Study Name: A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease Condition: Sialorrhoea Date: 2011-06-08 Interventions: Drug: OC oral solution treatment A |
Completed |
Study Name: Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation Condition: Sialorrhea Date: 2010-08-27 Interventions: Drug: Atropine (0.01mg/kg) Atr |
Completed |
Study Name: The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia Condition: Schizophrenia Clozapine Hypersalivat Date: 2010-01-05 Interventions: Drug: Suo Quan Wan, Wu Lin San |
Completed |
Study Name: Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients Condition: Sialorrhea Secondary to Parkinson's Disease Date: 2008-09-25 Interventions: Drug: 0.3 mg tropicamide 0.3 m |
Completed |
Study Name: FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey Condition: Weight Gain Sialorrhea Date: 2008-05-22 Interventions: Drug: FazaClo (clozapine, USP) ODT |
Completed |
Study Name: Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation Condition: Clozapine-induced Hypersalivation Date: 2007-09-24 Interventions: Drug: Amisulpride, Moclobemide Amisulpride 400 mg/d; Moclobemide 300 mg/d every medication for 2 week ai |
Completed |
Study Name: A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients Condition: Drooling Date: 2007-08-10 Interventions: Biological: Botulinum Toxin Type B (Myobloc) |
Completed |
Study Name: Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide Condition: Hypersalivation Date: 2006-09-26 Interventions: Drug: ipratropium bromide 0.03% spray |
Completed |
Study Name: Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) Condition: Amyotrophic Lateral Sclerosis Sialorrhea Date: 2005-07-27 Interventions: Drug: Botulinum toxin type B (Myobloc) Pro |